Comparison between a GnRH antagonist and a GnRH agonist flare-up protocol in oocyte donors: a randomized clinical trial

By Bodri D.   Vernaeve V.   Guillén J.J.   Vidal R.   Figueras F.   Coll O.  

Human Reproduction, Vol. 21, Iss. 9, 2006-09 ,pp. : 2246-2251

Oxford University Press

Access to resources Recommend Favorite

The value of pre-operative treatment with GnRH analogues in women with submucous fibroids: a double-blind, placebo-controlled randomized trial

By Mavrelos Dimitrios   Ben-Nagi Jara   Davies Anthony   Lee Christopher   Salim Rehan   Jurkovic Davor  

Human Reproduction, Vol. 25, Iss. 9, 2010-09 ,pp. : 2264-2269

Oxford University Press

Access to resources Recommend Favorite

GnRH agonist protocol administration in the luteal phase in ICSIET cycles stimulated with the long GnRH agonistprotocol: a randomized, controlled double blind study

By Ata B.   Yakin K.   Balaban B.   Urman B.  

Human Reproduction, Vol. 23, Iss. 3, 2008-03 ,pp. : 668-673

Oxford University Press

Access to resources Recommend Favorite

A randomized, double‐blind, multicentre clinical trial comparing starting doses of 150 and 200 IU of recombinant FSH in women treated with the GnRH antagonist ganirelix for assisted reproduction

By Out Henk J.  

Human Reproduction, Vol. 19, Iss. 1, 2004-01 ,pp. : 90-95

Oxford University Press

Access to resources Recommend Favorite

Flexible GnRH antagonist versus flare-up GnRH agonist protocol in poor responders treated by IVF: a randomized controlled trial

By Lainas Trifon G.   Sfontouris Ioannis A.   Papanikolaou Evangelos G.   Zorzovilis John Z.   Petsas George K.   Lainas George T.   Kolibianakis Efstratios M.  

Human Reproduction, Vol. 23, Iss. 6, 2008-06 ,pp. : 1355-1358

Oxford University Press

Access to resources Recommend Favorite